Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients

[11] Kotsou S(2005)Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis Cytokine 29 169-1663

[12] Marik PE(2010)Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia Crit Care 14 R27-64

[13] Van Cromphaut SJ(2007)Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med 167 1655-353

[14] Vanhorebeek I(2011)Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis J Crit Care 26 54-874

[15] Van den Berghe G(2010)SIRS score on admission and initial concentration of IL-6 as severe acute pancreatitis outcome predictors Hepatogastroenterology 57 349-559

[16] Losser MR(1992)Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 864-E228

[17] Damoisel C(2002)Inflammatory status and insulin resistance Curr Opin Clin Nutr Metab Care 5 551-45784

[18] Payen D(1995)Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance Am J Physiol 268 E219-812

[19] Dellinger RP(2003)Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects J Biol Chem 278 45777-862

[20] Carlet JM(2002)Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors Diabetologia 45 805-139

[11] Kotsou S(2005)Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis Cytokine 29 169-1663

[12] Marik PE(2010)Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia Crit Care 14 R27-64

[13] Van Cromphaut SJ(2007)Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med 167 1655-353

[14] Vanhorebeek I(2011)Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis J Crit Care 26 54-874

[15] Van den Berghe G(2010)SIRS score on admission and initial concentration of IL-6 as severe acute pancreatitis outcome predictors Hepatogastroenterology 57 349-559

[16] Losser MR(1992)Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 864-E228

[17] Damoisel C(2002)Inflammatory status and insulin resistance Curr Opin Clin Nutr Metab Care 5 551-45784

[18] Payen D(1995)Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance Am J Physiol 268 E219-812

[19] Dellinger RP(2003)Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects J Biol Chem 278 45777-862

[20] Carlet JM(2002)Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors Diabetologia 45 805-139